Pesquisa | Portal de Pesquisa da BVS Enfermagem

1.

Using birth-death processes to infer tumor subpopulation structure from live-cell imaging drug screening data.

Wu, Chenyu; Gunnarsson, Einar Bjarki; Myklebust, Even Moa; Köhn-Luque, Alvaro; Tadele, Dagim Shiferaw; Enserink, Jorrit Martijn; Frigessi, Arnoldo; Foo, Jasmine; Leder, Kevin.

PLoS Comput Biol ; 20(3): e1011888, 2024 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-38446830

2.

Statistical inference of the rates of cell proliferation and phenotypic switching in cancer.

Gunnarsson, Einar Bjarki; Foo, Jasmine; Leder, Kevin.

J Theor Biol ; 568: 111497, 2023 07 07.

Artigo em Inglês | MEDLINE | ID: mdl-37087049

3.

A comparison of mutation and amplification-driven resistance mechanisms and their impacts on tumor recurrence.

Li, Aaron; Kibby, Danika; Foo, Jasmine.

J Math Biol ; 87(4): 59, 2023 09 14.

Artigo em Inglês | MEDLINE | ID: mdl-37707631

4.

Roadmap on plasticity and epigenetics in cancer.

Foo, Jasmine; Basanta, David; Rockne, Russell C; Strelez, Carly; Shah, Curran; Ghaffarian, Kimya; Mumenthaler, Shannon M; Mitchell, Kelly; Lathia, Justin D; Frankhouser, David; Branciamore, Sergio; Kuo, Ya-Huei; Marcucci, Guido; Velde, Robert Vander; Marusyk, Andriy; Huang, Sui; Hari, Kishore; Jolly, Mohit Kumar; Hatzikirou, Haralampos; Poels, Kamrine E; Spilker, Mary E; Shtylla, Blerta; Robertson-Tessi, Mark; Anderson, Alexander R A.

Phys Biol ; 19(3)2022 04 18.

Artigo em Inglês | MEDLINE | ID: mdl-35078159

5.

Exact site frequency spectra of neutrally evolving tumors: A transition between power laws reveals a signature of cell viability.

Gunnarsson, Einar Bjarki; Leder, Kevin; Foo, Jasmine.

Theor Popul Biol ; 142: 67-90, 2021 12.

Artigo em Inglês | MEDLINE | ID: mdl-34560155

6.

Memory in Trait Macroevolution.

Goldberg, Emma E; Foo, Jasmine.

Am Nat ; 195(2): 300-314, 2020 02.

Artigo em Inglês | MEDLINE | ID: mdl-32017618

7.

Understanding the role of phenotypic switching in cancer drug resistance.

Gunnarsson, Einar Bjarki; De, Subhajyoti; Leder, Kevin; Foo, Jasmine.

J Theor Biol ; 490: 110162, 2020 04 07.

Artigo em Inglês | MEDLINE | ID: mdl-31953135

8.

Combination therapeutics of Nilotinib and radiation in acute lymphoblastic leukemia as an effective method against drug-resistance.

Kaveh, Kamran; Takahashi, Yutaka; Farrar, Michael A; Storme, Guy; Guido, Marcucci; Piepenburg, Jamie; Penning, Jackson; Foo, Jasmine; Leder, Kevin Z; Hui, Susanta K.

PLoS Comput Biol ; 13(7): e1005482, 2017 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-28683103

9.

Optimized Treatment Schedules for Chronic Myeloid Leukemia.

He, Qie; Zhu, Junfeng; Dingli, David; Foo, Jasmine; Leder, Kevin Zox.

PLoS Comput Biol ; 12(10): e1005129, 2016 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-27764087

10.

Leveraging Hypoxia-Activated Prodrugs to Prevent Drug Resistance in Solid Tumors.

Lindsay, Danika; Garvey, Colleen M; Mumenthaler, Shannon M; Foo, Jasmine.

PLoS Comput Biol ; 12(8): e1005077, 2016 08.

Artigo em Inglês | MEDLINE | ID: mdl-27560187

11.

An Evolutionary Approach for Identifying Driver Mutations in Colorectal Cancer.

Foo, Jasmine; Liu, Lin L; Leder, Kevin; Riester, Markus; Iwasa, Yoh; Lengauer, Christoph; Michor, Franziska.

PLoS Comput Biol ; 11(9): e1004350, 2015 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-26379039

12.

Evolution of acquired resistance to anti-cancer therapy.

Foo, Jasmine; Michor, Franziska.

J Theor Biol ; 355: 10-20, 2014 Aug 21.

Artigo em Inglês | MEDLINE | ID: mdl-24681298

13.

Multifocality and recurrence risk: a quantitative model of field cancerization.

Foo, Jasmine; Leder, Kevin; Ryser, Marc D.

J Theor Biol ; 355: 170-84, 2014 Aug 21.

Artigo em Inglês | MEDLINE | ID: mdl-24735903

14.

A Comparison of Mutation and Amplification-Driven Resistance Mechanisms and Their Impacts on Tumor Recurrence.

Li, Aaron; Kibby, Danika; Foo, Jasmine.

ArXiv ; 2023 Aug 21.

Artigo em Inglês | MEDLINE | ID: mdl-37396604

15.

Statistical inference of the rates of cell proliferation and phenotypic switching in cancer.

Gunnarsson, Einar Bjarki; Foo, Jasmine; Leder, Kevin.

ArXiv ; 2023 Jun 13.

Artigo em Inglês | MEDLINE | ID: mdl-37396613

16.

Phenotypic deconvolution in heterogeneous cancer cell populations using drug-screening data.

Köhn-Luque, Alvaro; Myklebust, Even Moa; Tadele, Dagim Shiferaw; Giliberto, Mariaserena; Schmiester, Leonard; Noory, Jasmine; Harivel, Elise; Arsenteva, Polina; Mumenthaler, Shannon M; Schjesvold, Fredrik; Taskén, Kjetil; Enserink, Jorrit M; Leder, Kevin; Frigessi, Arnoldo; Foo, Jasmine.

Cell Rep Methods ; 3(3): 100417, 2023 03 27.

Artigo em Inglês | MEDLINE | ID: mdl-37056380

17.

Selection pressure exerted by imatinib therapy leads to disparate outcomes of imatinib discontinuation trials.

Tang, Min; Foo, Jasmine; Gönen, Mithat; Guilhot, Joëlle; Mahon, François-Xavier; Michor, Franziska.

Haematologica ; 97(10): 1553-61, 2012 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-22419579

18.

Dose-dependent differential mRNA target selection and regulation by let-7a-7f and miR-17-92 cluster microRNAs.

Shu, Jingmin; Xia, Zhilian; Li, Lihua; Liang, Ellen T; Slipek, Nicholas; Shen, Dawen; Foo, Jasmine; Subramanian, Subbaya; Steer, Clifford J.

RNA Biol ; 9(10): 1275-87, 2012 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-22995834

19.

Stochastic dynamics of cancer initiation.

Foo, Jasmine; Leder, Kevin; Michor, Franziska.

Phys Biol ; 8(1): 015002, 2011 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-21301064

20.

Evolutionary modeling of combination treatment strategies to overcome resistance to tyrosine kinase inhibitors in non-small cell lung cancer.

Mumenthaler, Shannon M; Foo, Jasmine; Leder, Kevin; Choi, Nathan C; Agus, David B; Pao, William; Mallick, Parag; Michor, Franziska.

Mol Pharm ; 8(6): 2069-79, 2011 Dec 05.

Artigo em Inglês | MEDLINE | ID: mdl-21995722

Portal de Pesquisa da BVS Enfermagem

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar:

Using birth-death processes to infer tumor subpopulation structure from live-cell imaging drug screening data.

Statistical inference of the rates of cell proliferation and phenotypic switching in cancer.

A comparison of mutation and amplification-driven resistance mechanisms and their impacts on tumor recurrence.

Roadmap on plasticity and epigenetics in cancer.

Exact site frequency spectra of neutrally evolving tumors: A transition between power laws reveals a signature of cell viability.

Memory in Trait Macroevolution.

Understanding the role of phenotypic switching in cancer drug resistance.

Combination therapeutics of Nilotinib and radiation in acute lymphoblastic leukemia as an effective method against drug-resistance.

Optimized Treatment Schedules for Chronic Myeloid Leukemia.

Leveraging Hypoxia-Activated Prodrugs to Prevent Drug Resistance in Solid Tumors.

An Evolutionary Approach for Identifying Driver Mutations in Colorectal Cancer.

Evolution of acquired resistance to anti-cancer therapy.

Multifocality and recurrence risk: a quantitative model of field cancerization.

A Comparison of Mutation and Amplification-Driven Resistance Mechanisms and Their Impacts on Tumor Recurrence.

Statistical inference of the rates of cell proliferation and phenotypic switching in cancer.

Phenotypic deconvolution in heterogeneous cancer cell populations using drug-screening data.

Selection pressure exerted by imatinib therapy leads to disparate outcomes of imatinib discontinuation trials.

Dose-dependent differential mRNA target selection and regulation by let-7a-7f and miR-17-92 cluster microRNAs.

Stochastic dynamics of cancer initiation.

Evolutionary modeling of combination treatment strategies to overcome resistance to tyrosine kinase inhibitors in non-small cell lung cancer.